Skip to main content
. 2016 Sep 1;6(9):e010524. doi: 10.1136/bmjopen-2015-010524

Table 2.

Sensitivity analysis on studies with sample sizes of 100 or above

Outcome Substudies (n) Pooled sample size Heterogeneity
Overall effect
I2 (%) p Value MD (95% CI) p Value
HbA1c 11 2953 72 <0.0001 −0.29 (−0.44 to −0.14) 0.0001
FPG 2 1299 0 0.4186 −0.21 (−0.56 to 0.14) 0.2384
BMI 6 1174 97 0.0025 −0.89 (−1.88 to 0.09) 0.0757
DBP 6 1678 65 0.0269 −0.82 (−2.24 to 0.61) 0.2628
SBP 7 1740 65 0.0100 −1.08 (−3.46 to 1.29) 0.3710
HDL 3 384 79 0.0066 0.04 (−0.11 to 0.18) 0.6268
LDL 3 384 89 0.0009 −0.13 (−0.66 to 0.39) 0.6140
TG 4 607 0 0.6740 0.03 (−0.15 to 0.21) 0.7529
TC 6 1213 7 0.3190 −0.11 (−0.21 to −0.01) 0.0254
Weight 5 1641 0 0.9447 −0.28 (−0.62 to 0.07) 0.1172
WC 3 384 13 0.2934 −3.15 (−6.46 to 0.17) 0.0630

BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HbA1c, glycated haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MD, mean difference; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; WC, waist circumference.